Enable Biosciences’ Chief Technology Officer Jason Tsai, Ph.D. attended the American Association of Clinical Chemistry (AACC) annual conference July 29–August 2, 2018. Dr. Tsai was honored with the 2018 AACC Industry Division Best Abstract Award for his presentation describing the unique features, performance and benefits of Enable Biosciences’ Antibody Detection by Agglutination-PCR platform as applied to the diagnosis of a range of challenging diseases.
“The AACC is a leading global scientific and medical professional organization dedicated to clinical laboratory science and its application to healthcare. It was a privilege to accept the Best Abstract Award, which highlights the promise that Enable Biosciences’ technology shows for advancing laboratory medicine and clinical care,” said Dr. Tsai, “It is a very exciting time for clinical testing and I am pleased to be a part of a dynamic team that is on the forefront of innovative new diagnostic technologies.”
About the 2018 American Association of Clinical Chemistry Annual Conference in Chicago: The 70th AACC Annual Scientific Meeting & Clinical Lab Expo held July 29–August 2, 2018 was a premiere place where breakthroughs in clinical testing and patient care were introduced to the healthcare world. The meeting attracted global leaders in clinical chemistry, molecular diagnostics, precision medicine, mass spectrometry, translational medicine, lab management, and other major areas of laboratory medicine.